Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer

被引：0
|
作者：
S. H. Waters
A. Gillibrand
H. Berry
S. Kumar
G. Velikova
D. J. Dodwell
Timothy J. Perren
机构：
[1] St James’s Institute of Oncology,
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Anthracyclines; Antineoplastic combined chemotherapy protocols; Breast neoplasms; Capecitabine; Taxoids;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：407 / 412
页数：5
相关论文
共 50 条
  • [1] Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer
    Waters, S. H.
    Gillibrand, A.
    Berry, H.
    Kumar, S.
    Velikova, G.
    Dodwell, D. J.
    Perren, Timothy J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 407 - 412
  • [2] Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer
    Venturini, M
    Del Mastro, L
    Garrone, O
    Angiolini, C
    Merlano, M
    Bergaglio, M
    Tolino, G
    Lambiase, A
    Baldini, A
    Canavese, G
    Rosso, R
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 546 - 552
  • [3] Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer
    Pagani, O
    Sessa, C
    Nolè, F
    Munzone, E
    Crivellari, D
    Lombardi, D
    Thürlimann, B
    Hess, D
    Graffeo, R
    Ruggeri, M
    Longhi, S
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1609 - 1617
  • [4] A phase I dose-finding study of capecitabine in combination with epirubicin and docetaxel as first-line chemotherapy in advanced breast cancer patients.
    Angiolini, C
    Venturini, M
    Del Mastre, L
    Bergaglio, M
    Garrone, O
    Merlano, M
    Tolino, G
    Lambiase, A
    Bighin, C
    Stevani, I
    Catzeddu, T
    Bertelli, G
    Rosso, R
    ANNALS OF ONCOLOGY, 2000, 11 : 36 - 36
  • [5] Dose-finding study of high-dose epirubicin (E) and docetaxel (D) as first-line chemotherapy in advanced breast cancer (ABC)
    Pagani, O
    Sessa, C
    Vandenbulcke, T
    Martinelli, G
    Zampino, G
    Nole, F
    Zimatore, M
    Locatelli, M
    Crivellari, D
    Buonadonna, A
    Thurlimann, B
    Hess, D
    Borner, M
    Bauer, J
    Riggi, M
    Riva, A
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1998, 9 : 16 - 16
  • [6] Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer
    Pagani, O
    Sessa, C
    Martinelli, G
    Crivellari, D
    Buonadonna, A
    Thürlimann, B
    Hess, D
    Borner, M
    Bauer, J
    Zampino, G
    Zimatore, M
    Graffeo, R
    Riva, A
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1999, 10 (05) : 539 - 545
  • [7] Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer
    Misset, JL
    Dieras, V
    Gruia, G
    Bourgeois, H
    Cvitkovic, E
    Kalla, S
    Bozec, L
    Beuzeboc, P
    Jasmin, C
    Aussel, JP
    Riva, A
    Azli, N
    Pouillart, P
    ANNALS OF ONCOLOGY, 1999, 10 (05) : 553 - 560
  • [8] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    Gamucci, T.
    D'Ottavio, A. M.
    Magnolfi, E.
    Barduagni, M.
    Vaccaro, A.
    Sperduti, I.
    Moscetti, L.
    Belli, F.
    Meliffi, L.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1040 - 1045
  • [9] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    T Gamucci
    A M D'Ottavio
    E Magnolfi
    M Barduagni
    A Vaccaro
    I Sperduti
    L Moscetti
    F Belli
    L Meliffi
    British Journal of Cancer, 2007, 97 : 1040 - 1045
  • [10] WEEKLY EPIRUBICIN AND DOCETAXEL AS FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    D'Ottavio, A.
    Vaccaro, A.
    Belli, F.
    Nunziata, C.
    Meliffi, L.
    Moscetti, L.
    Barduagni, M.
    Sperduti, I.
    Gamucci, T.
    ANNALS OF ONCOLOGY, 2004, 15 : 19 - 19
12345